Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19

BACKGROUND: Krebs von den Lungen-6 (KL-6) is a known biomarker for diagnosis and monitoring of interstitial lung diseases. However, the role of serum KL-6 and the mucin 1 (MUC1) variant (rs4072037) in COVID-19 outcomes remains to be elucidated. We aimed to evaluate the relationships among serum KL-6...

Descripción completa

Detalles Bibliográficos
Autores principales: Azekawa, Shuhei, Chubachi, Shotaro, Asakura, Takanori, Namkoong, Ho, Sato, Yasunori, Edahiro, Ryuya, Lee, Ho, Tanaka, Hiromu, Otake, Shiro, Nakagawara, Kensuke, Fukushima, Takahiro, Watase, Mayuko, Sakurai, Kaori, Kusumoto, Tatsuya, Masaki, Katsunori, Kamata, Hirofumi, Ishii, Makoto, Hasegawa, Naoki, Okada, Yukinori, Koike, Ryuji, Kitagawa, Yuko, Kimura, Akinori, Imoto, Seiya, Miyano, Satoru, Ogawa, Seishi, Kanai, Takanori, Fukunaga, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Respiratory Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230347/
https://www.ncbi.nlm.nih.gov/pubmed/37230764
http://dx.doi.org/10.1136/bmjresp-2023-001625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230347/
https://www.ncbi.nlm.nih.gov/pubmed/37230764
http://dx.doi.org/10.1136/bmjresp-2023-001625

Ejemplares similares